XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Collaboration and Licensing Agreements - Additional Information (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenues $ 288.9 $ 302.4 $ 525.5 $ 539.5
Product sales, net        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenues 266.8 267.6 497.8 498.7
Takeda        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential milestone payments 1,900.0   1,900.0  
Idorsia        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential milestone payments 1,700.0   1,700.0  
Xenon        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential milestone payments 1,700.0   1,700.0  
Voyager        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential milestone payments 1,300.0   1,300.0  
BIAL        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential milestone payments 75.0   75.0  
BIAL | Product sales, net        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenues 2.0   3.4  
MTPC | License        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenues 15.0      
Deferred revenue recognized 1.3   2.4 1.3
Deferred revenue, balance 4.4   4.4  
Potential milestone payment receipts 55.0   55.0  
AbbVie | Royalty        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenues 5.9 $ 4.8 10.4 $ 9.5
Potential milestone payment receipts $ 366.0   $ 366.0